Avid Bioservices, Inc. (CDMO)
NASDAQ: CDMO · IEX Real-Time Price · USD
9.45
-0.05 (-0.53%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Avid Bioservices Market Cap
Avid Bioservices has a market cap or net worth of $600.84 million as of July 22, 2024. Its market cap has decreased by -30.34% in one year.
Market Cap
600.84M
Enterprise Value
769.12M
1-Year Change
-30.34%
Ranking
Category
Stock Price
$9.45
Market Cap Chart
Since December 1, 1998, Avid Bioservices's market cap has increased from $64.40M to $600.84M, an increase of 832.98%. That is a compound annual growth rate of 9.10%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 600.80M | 46.14% |
Dec 29, 2023 | 411.10M | -52.09% |
Dec 30, 2022 | 858.00M | -52.25% |
Dec 31, 2021 | 1.80B | 174.50% |
Dec 31, 2020 | 654.60M | 51.49% |
Dec 31, 2019 | 432.10M | 87.95% |
Dec 31, 2018 | 229.90M | 31.07% |
Dec 29, 2017 | 175.40M | 121.19% |
Dec 30, 2016 | 79.30M | -70.50% |
Dec 31, 2015 | 268.80M | 6.20% |
Dec 31, 2014 | 253.10M | 13.55% |
Dec 31, 2013 | 222.90M | 27.37% |
Dec 31, 2012 | 175.00M | 95.75% |
Dec 30, 2011 | 89.40M | -39.18% |
Dec 31, 2010 | 147.00M | 1.03% |
Dec 31, 2009 | 145.50M | 121.80% |
Dec 31, 2008 | 65.60M | -21.62% |
Dec 31, 2007 | 83.70M | -63.01% |
Dec 29, 2006 | 226.30M | 39.78% |
Dec 30, 2005 | 161.90M | -4.14% |
Dec 31, 2004 | 168.90M | -44.50% |
Dec 31, 2003 | 304.30M | 227.91% |
Dec 31, 2002 | 92.80M | -75.07% |
Dec 31, 2001 | 372.30M | 311.38% |
Dec 29, 2000 | 90.50M | 110.47% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
ProKidney | 606.52M |
Larimar Therapeutics | 606.12M |
Emergent BioSolutions | 605.95M |
Adaptive Biotechnologies | 602.74M |
Annexon | 600.86M |
GH Research | 597.80M |
Pharming Group | 594.92M |
Surmodics | 593.73M |